Statins

Statins

Do not change your medication regimen without consulting your doctor, as they are best equipped to interpret the results to make informed decisions about your healthcare.

Statins

A class of cholesterol-lowering drugs that inhibit the enzyme responsible for cholesterol synthesis. They help prevent cardiovascular diseases by lowering LDL cholesterol and reducing plaque buildup in arteries.

Below is a list of medications from this group that are included in the Macromo DNA Premium and Macromo DNA Platinum tests. Please note that some of the medications might be included in multiple groups.

  • Atorvastatin
  • Fluvastatin
  • Lovastatin
  • Pitavastatin
  • Pravastatin
  • Rosuvastatin
  • Simvastatin

Disclaimer

Our DNA test provides information about your medication metabolism, which helps your doctor in determining the best treatment plan for you. It is important to note that it is not a substitute for medical advice. Do not change your medication regimen without consulting your doctor, as they are best equipped to interpret the results to make informed decisions about your healthcare.

Improve your Health

Get the guidelines for a healthier and longer life. With Macromo tests, you'll learn your health risks and how to prevent them.

Continue to Shop

Recommendations

Our DNA test provides information about your medication metabolism, which helps your doctor in determining the best treatment plan for you. It is important to note that it is not a substitute for medical advice. Do not change your medication regimen without consulting your doctor, as they are best equipped to interpret the results to make informed decisions about your healthcare.

Sources

M. Whirl-Carrillo1, R. Huddart1, L. Gong, K. Sangkuhl, C.F. Thorn, R. Whaley and T.E. Klein. "An evidence-based framework for evaluating pharmacogenomics knowledge for personalized medicine" Clinical Pharmacology & Therapeutics (2021) online ahead of print.

Relling MV, Klein TE. CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network. Clin Pharmacol Ther. 2011;89(3):464-467. doi:10.1038/clpt.2010.279

Related Articles